CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 28 enrolled
Drug / intervention
Collagenase Santyl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00651820
NCT00651820Phase 4Completed
CompareCT.gov

A Randomized, Double-blind, Paired-Comparison of the Effect of Collagenase Santyl® Ointment on Healing and Scarring Characteristics of 600μm Dermatome Wounds

Healthpoint·interventional·Posted Apr 3, 2008·Updated Jun 9, 2011

In Brief

A Phase 4 clinical trial evaluating Collagenase Santyl and Collagenase Santyl Vehicle for Scarring and Impaired Wound Healing. Completed, enrolled 28 participants across 1 site.

Detailed Summary

A study to compare the rate of complete wound closure and quality of resulting scar at 3, 6 and 9 months, between dermatome-induced skin wounds treated with Collagenase Santyl Ointment versus vehicle alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScarring, Impaired Wound Healing
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 3, 2008
Enrollment StartApr 1, 2008
Primary CompletionNov 1, 2009
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 18.2 years ago

Interventions

Collagenase Santyldrug

Dermatome-induced skin wounds treated with drug active. Each subject serves as his own control receiving both treatments in parallel.

Collagenase Santyl Vehicledrug

Dermatome-induced skin wounds treated with Vehicle alone. Each subject serves as his own control receiving both treatments in parallel.